ATHNA BIOTECH INC
Watkinsville, GA · Biotech · Private
Sodium chloride nanoparticles (SCNPs) for intravesical bladder cancer therapy that induce immunogenic cell death
- Grants
- $2.5M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of a radiation-activatable nanoparticle for lung cancer therapy | $400,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of a radiation-activatable nanoparticle for lung cancer therapy | $400,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of a salt-based nanomedicine for non-muscle invasive bladder cancer | $399,907 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of a salt-based nanomedicine for non-muscle invasive bladder cancer | $399,907 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a radiation-activatable nanoparticle for lung cancer therapy | $901,390 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1665 | CURTANA PHARMACEUTICALS INC | — | — |
| 1666 | Pathfinder Therapeutics, Inc. | — | $9.6M |
| 1667 | CURIO BIOSCIENCE INC. | — | — |
| 1668 | ATHNA BIOTECH INC | — | — |
| 1669 | RYBODYN, INC. | — | — |
| 1670 | AXONEURAL THERAPEUTICS, INC. | — | — |
| 1671 | Ef Therapeutics LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.